Photys Therapeutics is a proximity-based therapeutics company with expertise across bifunctional platforms. This includes PROTACs, its proprietary PHICS™ (PHosphorylation Inducing Chimeric Small molecules) platform, and its proprietary tPRIME™ (targeted-PRoximity Induced Modulators of Expression) platform. Photys’ various approaches allows selective modulation of a target protein to achieve a desired alteration of the target’s biologic function, which may be applied in a tissue-selective or cell compartment-selective manner depending on the platform employed. Photys is applying its expertise across these modalities to advance a best-in-class pipeline of medicines in oncology, autoimmune, and cardiometabolic diseases. Photys is based in Waltham, Massachusetts.
